
Readouts across LBCL, relapsed/refractory myeloma, and CALR-mutated myelofibrosis anchored the hematology data presented at EHA 2026.
Shaji K. Kumar, MD, professor of medicine, Mayo Clinic, discusses the management of newly diagnosed patients with multiple myeloma.
Shaji K. Kumar, MD, professor of medicine, Mayo Clinic, discusses the management of newly diagnosed patients with multiple myeloma.
It is important to make the right diagnosis, says Kumar, especially when deciding when to start treatment for these patients.
Secondly, it is imperative that patients are properly risk-stratified—guidelines of which have been updated in the past few years. This gives a better sense of which patients will do well and which patients will not, Kumar adds.




